Combined Central and Peripheral Demyelination With IgM Anti-Neurofascin 155 Antibodies: Case Report
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Dalmau J, Dalakas M, Kolson D, Paul F, Sanchez-Valle R, Zamvil S Neurol Neuroimmunol Neuroinflamm. 2023; 10(1).
PMID: 36596717 PMC: 9827124. DOI: 10.1212/NXI.0000000000200076.
References
1.
Wang Z, Zhou X, Zhao N, Xie C, Zhu D, Guan Y
. Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations. Neurol Sci. 2021; 42(6):2223-2233.
DOI: 10.1007/s10072-021-05220-3.
View
2.
Man Ng J, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T
. Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology. 2012; 79(23):2241-8.
PMC: 3542349.
DOI: 10.1212/WNL.0b013e31827689ad.
View
3.
Martin-Aguilar L, Pascual-Goni E, Lleixa C, Frasquet M, Argente H, Cano-Abascal A
. Antibodies against nodo-paranodal proteins are not present in genetic neuropathies. Neurology. 2020; 95(4):e427-e433.
DOI: 10.1212/WNL.0000000000009189.
View
4.
Godil J, Barrett M, Ensrud E, Chahin N, Karam C
. Refractory CIDP: Clinical characteristics, antibodies and response to alternative treatment. J Neurol Sci. 2020; 418:117098.
DOI: 10.1016/j.jns.2020.117098.
View
5.
Burnor E, Yang L, Zhou H, Patterson K, Quinn C, Reilly M
. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies. Neurology. 2017; 90(1):e31-e38.
PMC: 5754648.
DOI: 10.1212/WNL.0000000000004773.
View